Valenti et al. used the MT bench assay to quantify FUS homotypic/heterotypic interactions in compartments of heterogeneous compositions in cells. They showed that FUS heterotypic interactions with other RBPs, orchestrated by its disease-related NLS, prevent FUS phase separation independently from nuclear transporters.